title: Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration.
abstract: We introduce a human retinal pigmented epithelial (RPE) cell-culture model that mimics several key aspects of early stage age-related macular degeneration (AMD). These include accumulation of sub-RPE deposits that contain molecular constituents of human drusen, and activation of complement leading to formation of deposit-associated terminal complement complexes. Abundant sub-RPE deposits that are rich in apolipoprotein E (APOE), a prominent drusen constituent, are formed by RPE cells grown on porous supports. Exposure to human serum results in selective, deposit-associated accumulation of additional known drusen components, including vitronectin, clusterin, and serum amyloid P, thus suggesting that specific protein-protein interactions contribute to the accretion of plasma proteins during drusen formation. Serum exposure also leads to complement activation, as evidenced by the generation of C5b-9 immunoreactive terminal complement complexes in association with APOE-containing deposits. Ultrastructural analyses reveal two morphologically distinct forms of deposits: One consisting of membrane-bounded multivesicular material, and the other of nonmembrane-bounded particle conglomerates. Collectively, these results suggest that drusen formation involves the accumulation of sub-RPE material rich in APOE, a prominent biosynthetic product of the RPE, which interacts with a select group of drusen-associated plasma proteins. Activation of the complement cascade appears to be mediated via the classical pathway by the binding of C1q to ligands in APOE-rich deposits, triggering direct activation of complement by C1q, deposition of terminal complement complexes and inflammatory sequelae. This model system will facilitate the analysis of molecular and cellular aspects of AMD pathogenesis, and the testing of new therapeutic agents for its treatment.
authors.affiliation: Center for the Study of Macular Degeneration, Neuroscience Research Institute, University of California, Santa Barbara, CA 93106, USA. l_johnso@lifesci.ucsb.edu
authors.forename: Lincoln V
authors.initials: LV
authors.lastname: Johnson
authors.forename: David L
authors.initials: DL
authors.lastname: Forest
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Banna
authors.forename: Carolyn M
authors.initials: CM
authors.lastname: Radeke
authors.forename: Michelle A
authors.initials: MA
authors.lastname: Maloney
authors.forename: Jane
authors.initials: J
authors.lastname: Hu
authors.forename: Christine N
authors.initials: CN
authors.lastname: Spencer
authors.forename: Aimee M
authors.initials: AM
authors.lastname: Walker
authors.forename: Marlene S
authors.initials: MS
authors.lastname: Tsie
authors.forename: Dean
authors.initials: D
authors.lastname: Bok
authors.forename: Monte J
authors.initials: MJ
authors.lastname: Radeke
authors.forename: Don H
authors.initials: DH
authors.lastname: Anderson
mesh_terms: D001057:Apolipoproteins E / Q000378:metabolism; D018929:Cell Culture Techniques; D003167:Complement Activation; D006801:Humans; D007150:Immunohistochemistry; D008268:Macular Degeneration / Q000378:metabolism / Q000473:pathology*; D008954:Models, Biological; D015593:Retinal Drusen / Q000473:pathology*; D055213:Retinal Pigment Epithelium / Q000378:metabolism / Q000473:pathology
chemical_list: D001057:Apolipoproteins E